Unexplained elevations of maternal serum alpha-fetoprotein.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Obstetrical and Gynecological Survey

• Publication date

  1990-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00006254-199011000-00001PMID 1700347
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Prenatal screening for neural tube defects: from maternal serum alpha-fetoprotein to ultrasonography

  2022cites this paper
• A Propose of Effective Model For Prediction of Spontaneous Preterm Delivery With Quadruple Serum Biomarkers of Aneuploidy Screening.

  2021cites this paper
• Associations between Maternal AFP and β-HCG and Preterm Birth

  2019cites this paper
• Clinical Significance of Abnormal Results of Second Trimester Hormones in the Absence of Aneuploidy

  2018cites this paper
• Second‐trimester maternal serum screening for fetal Down syndrome: As a screening test for hemoglobin Bart's disease: A prospective population‐based study

  2018cites this paper
• Placental abruption: Clinical features and diagnosis - UpToDate

  2017cites this paper
• Study on Elevated Maternal Serum Alpha-Fetoprotein in Second Trimester and Pregnancy Outcome

  2015cites this paper
• Acquired Bleeding Disorders in Pregnancy: Obstetric Hemorrhage

  2015cites this paper
• Second trimester maternal serum alpha‐fetoprotein (MSAFP) as predictor of fetal hemoglobin Bart's disease

  2014cites this paper
• Maternal Serum Screening Markers and Adverse Outcome: A New Perspective

  2014cites this paper
• Screening for abnormal placentation and adverse pregnancy outcomes with maternal serum biomarkers in the second trimester

  2014cites this paper
• Clinical and Pathologic Features of Placental Abruption: A Focus on the Pathologistʼs Role

  2010cites this paper
• Etiology, clinical manifestations, and prediction of placental abruption

  2010cites this paper
• The relationship between unexplained elevated serum markers in triple test, uterine artery Doppler measurements and adverse pregnancy outcome.

  2010cites this paper
• Maternal Serum Screening for Neural Tube and Other Defects

  2010cites this paper
• Partial monosomy 13 presenting with increased placental thickness and elevated maternal serum alpha-fetoprotein

  2009cites this paper
• Placenta Previa, Placenta Accreta, Abruptio Placentae, and Vasa Previa

  2009cites this paper
• Placental abruption : Studies on incidence, risk factors and potential predictive biomarkers

  2008cites this paper
• Second-trimester maternal serum alpha-fetoprotein elevation and its association with adverse maternal/fetal outcome: ten years experience.

  2007cites this paper
• L'hormone chorionique gonadotrophique et l'alpha-foetoprotéine : leur corrélation avec la pré-éclampsie

  2007cites this paper
• Biochemical markers for the prediction of preterm delivery.

  2007cites this paper
• Elevated maternal second‐trimester serum alpha‐fetoprotein as a risk factor for placental abruption

  2007cites this paper
• Antepartum and Postpartum Hemorrhage

  2007cites this paper
• Placental Abruption

  2006cites this paper
• Sirenomelia of an Intracytoplasmic Sperm Injection Conceptus: A Case Report and Review of Mechanism

  2006cites this paper
• Biochemical markers for the prediction of preterm labor.

  2005cites this paper
• Correlation of abnormal second trimester maternal serum alpha-fetoprotein (MSAFP) levels and adverse pregnancy outcome

  2005influential citation
• First and second‐trimester biochemical markers of chromosomal anomalies and their relationship to maternal haemoglobin levels

  2005cites this paper
• Guidance for the Clinician in Rendering Pediatric Care

  2004cites this paper
• Prenatal Diagnosis of Fetal Disorders

  2004cites this paper
• Levels of Alpha-Fetoprotein During Pregnancy and Early Infancy in Normal and Disease States

  2003cites this paper
• Fetal serum alpha‐fetoprotein in alloimmunised pregnancies

  2003cites this paper
• Management of obstetric hemorrhage.

  2003cites this paper
• Placental sonolucency and pregnancy outcome in women with elevated second trimester serum alpha-fetoprotein levels.

  2003cites this paper
• The association of abnormal alpha-fetoprotein and adverse pregnancy outcome: does increased fetal surveillance affect pregnancy outcome?

  2001cites this paper
• Second‐trimester maternal serum alpha‐fetoprotein (MSAFP) iselevated in women with adverse pregnancy outcome associated with inherited thrombophilias

  2001influential citation
• Alpha-fetoprotein Structure and Function: Relevance to Isoforms, Epitopes, and Conformational Variants

  2001cites this paper
• False positive serum biochemical screening and subsequent fetal loss in women less than 35 years of age

  2001cites this paper
• A Critical Birth Weight and Other Determinants of Survival for Infants with Severe Intrauterine Growth Restriction

  2001cites this paper
• Alpha‐Fetoprotein and Hematopoietic Growth Factors in Amniotic Fluid

  2000cites this paper
• Thrombomodulin: A New Marker for Placental Abruption

  1999cites this paper
• Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome.

  1999cites this paper
• Adverse obstetric outcome in low- and high- risk pregnancies: predictive value of maternal serum screening.

  1999cites this paper
• Predicting risk of preterm delivery by second-trimester measurement of maternal plasma corticotropin-releasing hormone and alpha-fetoprotein concentrations.

  1999cites this paper
• Association of Low Unconjugated Estriol in the Second Trimester and Adverse Pregnancy Outcome

  1998cites this paper
• Abnormal maternal serum alpha fetoprotein and pregnancy outcome.

  1998cites this paper
• Maternal serum alpha‐fetoprotein in placental abruption associated with preterm labor

  1997cites this paper
• Prediction of Adverse Perinatal Outcome By Maternal Serum Screening for Down Syndrome in an Asian Population

  1997cites this paper
• THE ASSOCIATION OF EARLY‐ONSET FETAL GROWTH RESTRICTION, ELEVATED MATERNAL SERUM ALPHA‐FETOPROTEIN, AND THE DEVELOPMENT OF SEVERE PRE‐ECLAMPSIA

  1997cites this paper
• Etiologies of fetal growth restriction.

  1997cites this paper
• Unexplained Elevated Maternal Serum Alpha‐Fetoprotein Levels and Pregnancy Outcome in Twins

  1996cites this paper
• PLACENTAL MOSAICISM IS ASSOCIATED WITH UNEXPLAINED SECOND‐TRIMESTER ELEVATION OF MShCG LEVELS, BUT NOT WITH ELEVATION OF MSAFP LEVELS

  1996cites this paper
• Majör Bir Obstetrik Risk; Plasenta Previa Perkreta-Olgu Sunumu

  1996cites this paper
• SECOND‐TRIMESTER MATERNAL SERUM ALPHA‐FETOPROTEIN, HUMAN CHORIONIC GONADOTROPIN, AND UNCONJUGATED OESTRIOL AFTER EARLY TRANSVAGINAL MULTIFETAL PREGNANCY REDUCTION

  1996cites this paper
• Neuronal overmaturation in dysraphism: ontogenic expression of neuropeptides in the fetal brain and developmental anomalies in exencephaly

  1995cites this paper
• Outcome of Pregnancies with Elevation of Both Maternal Serum Alpha-Fetoprotein and Human Chorionic Gonadotropin

  1995cites this paper
• Biochemical and Doppler predictors of poor perinatal outcome in a fetus with four umbilical vessels.

  1995cites this paper
• and Doppler predictors of poor perinatal fetus with four umbilical vessels outcome in a

  1995cites this paper
• Uterine artery Doppler velocimetry in the detection of adverse obstetric outcomes in women with unexplained elevated maternal serum alpha-fetoprotein levels.

  1995cites this paper
• Low dose aspirin in women with raised maternal serum alpha-fetoprotein and abnormal Doppler waveform patterns from the uteroplacental circulation.

  1994cites this paper
• Midtrimester hemoperitoneum caused by placenta percreta in association with elevated maternal serum alpha-fetoprotein level.

  1994cites this paper
• Adverse perinatal outcome in patients screen‐positive for neural tube defects and fetal down syndrome

  1994cites this paper
• Retraction: Doppler ultrasound of the uteroplacental circulation in the prediction of pregnancy outcome in women with raised maternal serum alpha‐fetoprotein

  1994cites this paper
• An association between elevated levels of human chorionic gonadotropin in the midtrimester and adverse pregnancy outcome.

  1993cites this paper
• Circulating intercellular adhesion molecule-1 in amniotic fluid, maternal serum alpha-fetoprotein levels, and intrauterine growth retardation.

  1993cites this paper
• Elevated maternal serum human chorionic gonadotropin increases the chance of adverse pregnancy outcome.

  1993cites this paper
• Presented by invitation at the Fifty-ninth Annual Meeting of the Pacific Coast Obstetrical and Gynecological Society, Ojai, California, October 11-18, 1992.

  1993cites this paper
• Elevated maternal serum alpha-fetoprotein associated with placenta accreta.

  1992cites this paper
• Elevated maternal serum alpha-fetoprotein levels and midtrimester placental abnormalities in relation to subsequent adverse pregnancy outcomes.

  1992cites this paper
• Elevated maternal serum α-fetoprotein associated with placenta accreta

  1992cites this paper
• Current issues in maternal serum alpha-fetoprotein screening.

  1992cites this paper
• Maternal serum alpha-fetoprotein screening.

  1991cites this paper